Ibrahim Eldessouky

Genvion Corporation

Genvion Corporation is an FDA approved CDMO, specialized in solid dosage and fully equipped to handle highly toxic API materials such as safe bridge level 4. Our comprehensive contract manufacturing services begin from the early stages of product development to clinical trials followed by commercial scale manufacturing and packaging for international market. GENVION's world-class operation, located in Winnipeg, Canada, is designed and maintained in accordance with current good manufacturing practices (cGMP). Our quality assurance and validation program ensure that all our operating procedures meet or exceed the highest standards of pharmaceutical product manufacturing. Our dedicated professional team is committed to excellence in all aspects of operations. Our aim is to become the preferred partner for our customers, with a commitment of being efficient to reduce costs and lead times, while maintaining the highest standards in quality.